NCT01057108View on ClinicalTrials.gov

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

PHASE1CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
HyperphosphatemiaChronic Kidney Disease
Interventions
OTHER

FOSTRAP Chewing Gum

20 mg BID

OTHER

FOSTRAP Chewing Gum

40 mg BID

OTHER

FOSTRAP Chewing Gum

20 mg TID

OTHER

FOSTRAP Chewing Gum

20 mg TID

OTHER

Placebo chewing gum

Trial Locations (1)

80230

Denver Nephrologists, PC, Denver

Sponsors

Collaborators (1)

CM&D Pharma Limited
All Listed Sponsors
collaborator

CM&D Pharma Limited

INDUSTRY

lead

Denver Nephrologists, P.C.

OTHER

NCT01057108 - Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia | Biotech Hunter | Biotech Hunter